Thread lift (실리프팅).

A thread lift passes a series of bio-absorbable threads (PDO — polydioxanone, or PLLA — poly-L-lactic acid) under the skin along predefined lift vectors. The threads have tiny barbs or cogs that catch tissue and pull it into a new position. The threads dissolve over 6–24 months, but collagen stimulation during that period can extend the effect.

Typically 35–55, with mild-to-moderate soft tissue descent along the cheek, jowl, or neck. Not a substitute for surgical facelift in advanced sagging. Often combined with skin boosters or HIFU for a compound effect.

Thread type (PDO has the longest track record in Korea; PLLA stimulates more collagen but costs more), expected duration, how many threads and along which vectors, anesthesia used, and what happens if a thread migrates or extrudes (rare, but the clinic should have a clear protocol).

2–5 days of visible swelling and small puncture marks at the entry points. Mild bruising possible. Most patients are presentable in under a week.

₩500,000–₩1,500,000 for a dermatology-tier session with fewer threads. ₩1,500,000–₩3,000,000 for a surgical-clinic tier with more threads and longer-duration PLLA material. Packages bundled with skin boosters are common.

"What percentage of your thread-lift patients are repeat customers within 18 months?" A high rate means the lift is short-lived; a low rate can mean either durable results or unhappy patients. Cross-check with reviews.

A Korean thread-lift (실리프팅) appointment is closer to a small office procedure than a casual injection visit. The session opens with a sit-up consultation in front of a mirror: the clinician marks the planned lift vectors with a surgical pen along the cheek, jowl, jawline, lateral brow, or upper neck, depending on the plan. Photographs are taken in repose and on smile, the entry points are sterilised, and the patient is laid back at roughly thirty degrees. Local anaesthetic is then injected as small wheals at each entry point, typically along the temples, the preauricular line, or the scalp behind the hairline, and along the planned thread tract beneath the skin. For a V-line thread (브이라인 실) involving the lower face and jawline, some clinics add a regional sensory nerve block to settle the deeper passes.

Once numbness is confirmed, the clinician makes 1 to 2 mm puncture entry points with a small blade or large-bore needle. A hollow cannula loaded with the absorbable thread is then advanced through the subcutaneous plane along the marked vector, the cannula is withdrawn leaving the thread in tissue, and the thread is anchored proximally with a measured lateral pull. Patients describe the sensation as a deep tugging or pulling, occasionally a brief scrape, and sometimes a low audible sound as the cannula moves through tissue planes — the colloquial Korean phrasing is the cog thread (코그실) sound. Most full thread-lift sessions take 30 to 60 minutes for 6 to 12 threads, longer for combined mid-face and jawline plans.

Day 0 typically leaves the clinic with an immediate visible lift, mild bruising at the entry points, light swelling, and small skin dimples or puckering along the thread tract that smooth out as the tissue settles. Day 7 the bruising has usually faded and the dimpling is softer, with most patients presentable at this point. Week 4 the visible lift looks more natural as residual tethering relaxes. Month 3 the secondary collagen response begins to layer in, which is when reputable Korean clinics schedule the formal review.

Thread lifting has a substantial published literature, dominated by Korean and broader East-Asian cohorts because the absorbable PDO (폴리디옥사논) thread category was popularised in Korean dermatology before crossing into Western practice. The picture is nuanced: complication rates are not zero, most events are minor and self-limiting, and a small number of serious complications are documented and worth understanding before consenting. Nothing in this section replaces a clinic-specific consultation, and none of it is medical advice. It is the published evidence as it stands.

On overall complication rates, a retrospective series of 160 PDO thread procedures characterised the early post-operative profile in detail, with displacement of barbed sutures, transient erythema, clinically insignificant infection, skin dimpling, and brief facial stiffness as the most common events. A two-year outcome study of absorbable barbed PDO threads with objective scoring (PMID: 28863268) reported a complication rate of approximately 4.8% across the cohort, alongside skin lift measurements of 3 to 10 mm sustained at follow-up. A 2025 Japanese multicentre review of more than 110,000 facial thread-lifting cases performed across more than 100 clinics over five years (PMID: 41346928) documented the modern East Asian volume picture and the pronounced shift toward combination protocols with filler and botulinum toxin. A serious bacterial complication report (PMID: 31299818) describes inflamed multiple palpable masses at thread sites that were not controlled by initial antibiotic therapy, which sits alongside an additional bacterial complication case (PMID: 35265439) in the evidence on rare but consequential infection events. A Turkish PDO cog series (PMID: 31267809) documents the thread-migration risk and a same-entry-point tying technique to reduce it, which has since been adopted in some Korean protocols.

On vascular events, the cannula technique used in modern Korean thread lifts substantially reduces but does not eliminate the risk of inadvertent vessel puncture; published vascular event rates with cannula-based thread placement remain low compared with sharp-needle filler injection in the same anatomical zones. Common self-limiting events across cohorts include bruising at entry points, persistent dimpling for two to four weeks, thread palpability at lift terminations, asymmetry that often equilibrates with tissue settling, and rare late extrusion or visibility through thin skin.

The contraindications worth raising at consultation. Pregnancy and breastfeeding: manufacturer labels and reputable Korean clinics decline elective thread lifting in both states until after weaning. Anticoagulant therapy and underlying bleeding disorders: thread lifting involves multiple subcutaneous passes and several puncture entry points, and unmanaged anticoagulation materially raises the bruising and haematoma risk. Active skin infection at the entry sites or along the planned thread tract: the procedure is postponed until the infection is fully resolved. Uncontrolled autoimmune disease, recent isotretinoin courses, and a history of keloid scarring are also commonly raised as relative contraindications. Discuss your full medical history and current medications with your provider before booking.

A thread lift does two things simultaneously, on different timelines. The first and immediate effect is mechanical: the barbs or cogs along the thread anchor into surrounding tissue and hold the soft-tissue plane in a new, slightly elevated position once the clinician applies the lateral lift vector. That is the visible day-0 result. The second, slower effect is biological: as the absorbable polymer is broken down and resorbed by the body, the foreign-material response stimulates a localised collagen and elastin deposition along the thread tract. PDO threads (폴리디옥사논) typically absorb over 6 to 9 months, polycaprolactone or PCL threads over 18 to 24 months, and PLLA poly-L-lactic acid threads over 24 months and longer. The clinical lift outlasts the physical thread by several months in most patients, with the secondary collagen layer providing a soft, residual support after the polymer itself has fully resorbed.

Korean target areas reflect what threads do well. The mid-face (광대 리프팅) is treated for cheek descent and early mid-cheek hollowing. The jawline is treated for V-line definition (브이라인) and early jowl softening. The lateral brow is lifted for a subtle eye-opening effect using thinner mono or fine-cog threads. The upper neck and submandibular area are treated for early laxity and platysmal banding when the descent is mild. The characteristic Korean indication is mild-to-moderate early laxity in patients aged roughly 30 to 50, used as either a non-surgical alternative or a pre-surgical bridging procedure.

What thread lifting does not do is the more important conversation. It does not replace a surgical facelift in patients with advanced soft-tissue descent or significant excess skin; the threads do not have the holding power for severe sagging and will pull through tissue rather than lifting it. It does not address volume loss; a flat cheek or hollow temple is filler or biostimulator territory. It does not soften deep static wrinkles carved into the dermis, which belong to laser resurfacing or skin boosters. It does not relax dynamic muscle lines, which are botulinum toxin work. And it is not permanent: even with collagen support, most patients see a tapering of the visible result across 12 to 18 months for PDO and 18 to 24 months for PCL, and choose either repeat sessions or a different modality at that point. Discuss with your provider which layer is actually driving the change you want.

Published outcome data for thread lifting have grown substantially since 2017, both for the PDO category and for the longer-duration PCL and PLLA materials. The clinical picture is consistent across cohorts: a measurable early lift on objective imaging, patient-reported satisfaction generally above 85%, and a tapering of the physical effect across 6 to 24 months that varies meaningfully by thread material, density, and operator technique.

On longevity and objective outcomes, the two-year cohort study of absorbable barbed PDO threads (PMID: 28863268) documented sustained skin lift measurements of 3 to 10 mm and a complication rate of about 4.8% across the follow-up window, with augmented results when thread lifting was paired with adjunctive modalities. A pilot study quantitatively evaluating jawline thread lifting using poli-lactic and poli-caprolactone threads (PMID: 34084008) reported significant improvement in tragus-to-marionette and tragus-to-jowl distances at a mean follow-up of 8.16 months, with all measured parameters improving significantly versus baseline. A combination study of PPDO thread lifting with hyaluronic-acid filler in middle-aged and elderly patients (PMID: 39038353) reported a total effective rate of 89.8% in the combination arm versus 72.1% in thread lift alone, with longer maintenance duration in the combined-modality group. A series describing mini-midface lifting using PDO cog threads (PMID: 32766067) confirmed satisfactory midface outcomes for at least six months in 64 women aged 33 to 60. A Korean vertical-lifting technique paper introducing a wedge-shaped PDO suture approach optimised for Asian skeletal anatomy (PMID: 28430736) is the most-cited Korean technique reference in the international literature.

On the histological and material side, an efficacy study of a polycaprolactone (PCL) thread compared with other commercial threads in a murine model (PMID: 33421303) reported significantly increased neocollagenesis, type III collagen, and TGF-β expression in the PCL group at 8 weeks, alongside roughly a 20% reduction in wrinkle depth versus comparator threads, supporting the longer-duration positioning of PCL in the Korean market. A subsequent histological and molecular biological analysis of PDO and PCL threads in a rat model (PMID: 34847267) showed increased collagen formation across all thread types in the first 12 weeks, with declining signal afterward — evidence that the collagen response is finite and tracks the absorption window rather than continuing indefinitely. A clinical and case-series review of PDO threads as a non-surgical alternative for facial rejuvenation (PMID: 32866981) consolidates the dermatologist's-eye view of indication selection and patient expectations.

Patient-reported outcomes across these cohorts converge on satisfaction rates above 85%, with the FACE-Q aesthetic module increasingly used as the standardised instrument. The honest read of the evidence is that threads work for the early-laxity indication they are designed for, that PCL and PLLA materials buy meaningfully longer duration than PDO, and that the published literature does not yet extend reliably beyond 24 months. Patient expectations, planned maintenance, and combination strategy should be discussed with your provider before booking.

Korean thread lift (한국 실리프팅) is one of the highest-volume search categories in international aesthetic queries, with terms such as korean thread lift, PDO thread lift seoul, V-line thread lift, thread lift cost korea, and Mint thread lift sitting at the top of inbound traffic to Gangnam clinic websites. The V-line thread (브이라인 실리프팅) — a jawline-and-lower-face contouring protocol designed to produce the slim, defined lower-face silhouette associated with K-pop and K-drama aesthetics — is the single most internationally recognised Korean thread-lift product category, frequently bundled with light masseter botulinum toxin and a small chin filler placement in a single visit.

Material innovation has accelerated. Mint thread (민트실), the most internationally recognised Korean PDO barbed-thread brand, sits alongside Aptos (만토실), Silhouette Soft, and the growing PCL thread category as the main material families a patient is likely to encounter in a Seoul clinic. PCL threads are positioned as the longer-lasting Korean innovation, with absorption over 18 to 24 months and a more sustained collagen response compared with the standard 6 to 9 month PDO window. Within each material, thread architecture varies — mono threads for fine biostimulation, screw or twin threads for low-grade volumising, and cog or barbed threads (코그실) for actual mechanical lift — and a thoughtful Korean consultation should match thread architecture to indication rather than offering a fixed house bundle.

Around the procedure, recovery and skin-quality add-ons have multiplied. Polynucleotide PDRN injectables (폴리뉴클레오타이드) such as Rejuran are commonly paired with thread lifting at the same visit or a few weeks after, used as a dermal-regeneration adjunct to soften the skin overlying the lift. Exosome facials (엑소좀) and post-procedure microneedling appear in many Gangnam stacking protocols. The aesthetic target across the whole stack is the glass skin (유리피부) endpoint — clear, light-reflecting, visibly lifted but not visibly procedural — rather than the more obvious lift-and-hold result associated with some Western thread-lift marketing. The single-visit Gangnam stacking pattern — thread lift plus skin booster plus targeted botulinum toxin — is now the dominant 2026 protocol for patients with mild-to-moderate early laxity who want a multimodal touch rather than any single-modality result. None of these combinations should be selected on search-trend volume alone.

Is it safe during pregnancy or breastfeeding? No. Manufacturer labels and reputable Korean clinics decline elective thread lifting in pregnancy and during breastfeeding. Treatment is postponed until after weaning. Ask your provider for their written policy.

Can I see results immediately? Yes, partly. Day 0 the lift is visibly present once you sit up from the chair, but it is overlaid with bruising at the entry points, mild swelling, and small skin dimples along the thread tract that smooth out across two to four weeks. The settled honest result is at week 4 to 6, with a secondary soft tissue improvement at month 3 as the collagen layer builds.

Will I feel the threads under my skin? Briefly, yes. Most patients report mild palpability at the entry points and along the lift termination for the first two to four weeks, and occasional brief tightness with wide jaw movements such as yawning or laughing for the first week. Persistent palpability or visible thread shadowing beyond the first month should be reviewed with your clinic.

Can I have an MRI after a thread lift? Yes — absorbable PDO, PCL, and PLLA threads are non-metallic and are not an MRI contraindication. Inform the radiologist of the recent procedure for completeness, but the threads do not interfere with imaging or pose a magnetic safety risk.

How long until I can exercise? Most Korean clinics advise avoiding strenuous exercise, weight training, and hot yoga for two weeks, and avoiding combat or contact sports for at least four weeks. Light walking is generally permitted from day 1. Discuss your specific routine with your provider.

Will my smile look weird temporarily? Often, briefly. Mid-face and jawline thread placement can produce a temporary stiffness on wide smiling for the first one to two weeks as the tissue settles, occasionally with a small asymmetric pull. This usually resolves spontaneously by week four. Persistent smile asymmetry beyond that window should be reviewed.

What if I do not like the result? Threads cannot be dissolved the way hyaluronic-acid filler can. Most asymmetries and dimpling resolve over two to four weeks as tissue settles. Persistent issues are usually managed by waiting for partial absorption, gentle massage, or in rare cases surgical retrieval of a palpable thread. Ask your clinic in advance about their revision policy and timeline.

How does this compare to a facelift? A thread lift is a non-surgical, lower-cost, lower-downtime option for mild-to-moderate early laxity, with a duration measured in months to two years rather than the years to a decade typical of surgical results. It is not a facelift substitute for advanced descent. A surgical facelift addresses excess skin and deep structural sagging that thread lifting cannot. Many Korean clinics use threads as a bridging procedure in patients who are not yet surgical candidates, and step to surgery later when the indication crosses that threshold.

Are Korean PDO threads better than Western brands? The published comparative data are limited, and the honest answer in 2026 is that thread material category (PDO vs PCL vs PLLA), thread architecture (mono vs cog vs screw), and operator technique drive outcome more than country of manufacture. Korean brands such as Mint and the wider Korean PDO category have the largest published case volume and longest track record; PCL threads from Korean and other manufacturers buy longer duration. Discuss specific brand and material selection with your provider rather than choosing on national origin alone.

Can I combine with botox or filler? Yes — combining a thread lift with botulinum toxin and small-volume hyaluronic-acid filler in a single visit is a standard Korean stacking protocol, particularly for V-line work where masseter botox, chin filler, and a jawline thread lift are commonly performed together. Skin boosters such as Rejuran or Profhilo are often added at the same visit or a few weeks after for skin-quality recovery. Discuss the specific combination, sequencing, and combined downtime with your provider in advance.